NCT05926258 - Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

March 13, 2025

Study Completion Date

March 13, 2025

Conditions

Local Anesthetic

Interventions

DRUG

Chloroprocaine 3% eye gel

ocular surface anesthesia

DRUG

Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops

ocular surface anesthesia

Trial Locations (3)

IRCCS Ospedale San Raffaele, Milan

ASST Grande Ospedale Metropolitano Niguarda, Milan

Ospedale della Donna e del Bambino, Ospedale Borgo Trento, Azienda Ospedaliera Universitaria Integrata, Verona